Adult perception of risk, risk behaviour and HIV/AIDS
Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp 120
Complement-mediated enhancement of HIV-1 infection of the monoblastoid cell line U937
Performance characteristics of a novel immunoassay based on hybrid Ty virus-like particles (Ty-VLPs)
Inhibitory effect of novel 1-deoxynojirimycin derivatives on HIV-1 replication
Extrapulmonary and disseminated tuberculosis in HIV-1-seropositive patients presenting to the acute medical services in Nairobi
Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users
Immunological changes in primary HIV-1 infection
Impact of maternal HIV infection on obstetrical and early neonatal outcome
Monitoring HIV trends in injecting drug users
AIDS in the minds of Swedish people
Pneumocystis carinii pneumonia treated with eflornithine in AIDS patients resistant to conventional therapy
Seroepidemiology of HIV-1 infection in a Catalonian penitentiary
Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infection
Fibrinogen concetration in asymptomatic HIV-infected individuals
Maintenance therapy of oropheryngeal candidiasis in HIV-infected patients with fluconazole
Single dose therapy for esophageal candidates with fluconzole
Prevalence of pulmonary toxoplasmosis in HIV-infected patients
No effect of isoprinosine of HIV infection in vitro
The effect of Fusidic acid on Tanzanian patients with AIDS
Red cell aplasia associated with human parvovirus B19 and HIV infection
High prevalence of indeterminate Western blot tests for antibodies to HIV-1 in Tanzania
HIV-1 and HIV-2 antibodies in Nigerian populations with high- and low-risk behaviour patterns
Report on a European Community meeting on strategies for development and use of a future HIV vaccine
Statistics from the World Health Organization and the Centers for Disease Control